Results 191 to 200 of about 456,556 (361)

Temporal evolution of tumefactive neurolymphomatosis with serial MRI and positron emission tomography: illustrative case. [PDF]

J Neurosurg Case Lessons
Porche K, Amrami KK, Spinner RJ.
europepmc   +1 more source

Attenuation correction of myocardial perfusion scintigraphy images without transmission scanning

, 2015
Attenuation correction is essential for reliable interpretation of emission tomography; however the use of transmission measurements to generate attenuation maps is limited by availability of equipment and potential mismatches between the transmission ...
Cade, SC
core  

Sjögren Disease—B Cells at the Brink: From Autoimmunity to Lymphomagenesis and the Rise of Novel B Cell–Targeted Therapies

Arthritis &Rheumatology, EarlyView.
Sjögren disease (SjD) is a common systemic autoimmune disorder characterized by inflammation of the exocrine glands, resulting in dryness. Patients frequently exhibit extraglandular manifestations affecting various organ systems. To date, there are no US Food and Drug Administration (FDA)‐approved disease‐modifying therapies for SjD. In this review, we
Rachael A. Gordon, Sara S. McCoy
wiley   +1 more source

Serotonin and working memory in mood disorder and healthy states: multi-cohort positron emission tomography study. [PDF]

BJPsych Open
Dam VH, Johansen A, Gillings N, Svarer C, Miskowiak KW, Knudsen GM, Stenbæk DS, Frokjaer VG.   +7 more
europepmc   +1 more source

Advancing Clinical Research

Advanced Science, EarlyView.
wiley   +1 more source

Motion mitigation in positron-emission tomography guided radiotherapy delivered on a magnetic resonance imaging-linear accelerator. [PDF]

Phys Imaging Radiat Oncol
Everard AJ, Santo RJ, Borman PTS, Uijtewaal P, Fast MF, de Jong HWAM, van den Berg CAT, Raaymakers BW, Beijst C.   +8 more
europepmc   +1 more source

Integrated Clinical and Proteomic Profiling of CD19 Chimeric Antigen Receptor T Cell Therapy in Progressive Systemic Sclerosis

Arthritis &Rheumatology, EarlyView.
Objective To characterize the clinical, immunologic, and proteomic changes associated with CD19 chimeric antigen receptor T cell therapy in patients with progressive systemic sclerosis (SSc). Methods Patients with progressive SSc received CD19 chimeric antigen receptor (CAR)‐T cell therapy and were observed longitudinally for safety, clinical efficacy,
Chenhan Jia, Wanyi Lin, Zhangyi Zhao, Fenglin Wu, Chaoyu Gu, Yuankai Sun, Zhe Ding, Chang Wei, Xinyu Li, Cuiwei Xie, Peng Xia, Zhen Xia, Xuesong Liu, Shaoying Yang, Chunyan Zhang, Hanlin Yin, Liangjing Lu   +16 more
wiley   +1 more source

Ultra-dense lutetium oxide ceramic scintillators for positron emission tomography. [PDF]

Phys Med Biol
Hamato A, Lee D, Ota R, Hemmati H, Muller M, Wang Y, Pandian LS, Kim S, Yamaya T, Cherry SR, Glodo J, Kwon SI.   +11 more
europepmc   +1 more source

Expert Perspectives: Defining and Managing Progressive Pulmonary Fibrosis in Systemic Sclerosis

Arthritis &Rheumatology, EarlyView.
Systemic sclerosis–associated interstitial lung disease (SSc‐ILD) is one of the leading causes of morbidity and mortality in SSc, affecting up to three‐quarters of patients. The disease course is highly heterogeneous, ranging from indolent, nonprogressive forms to rapidly progressive pulmonary fibrosis (PPF).
Devis Benfaremo, Dinesh Khanna, Corrado Campochiaro, Vincent Cottin, Fabrizio Luppi, Marco Matucci‐Cerinic, Gianluca Moroncini, Yannick Allanore   +7 more
wiley   +1 more source

Positron emission tomography evidence of tracheal tube-induced posterior laryngeal pressure injury. [PDF]

Anaesth Rep
Fuentes S, Zhou T, Vahabzadeh-Hagh AM.
europepmc   +1 more source